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Summary
Rotavirus infection was detected in 39.9% of 1030
children hospitalized with gastroenteritis in Palermo,
Italy, in the period 2001–2005. Rotavirus strains
belonging to G1, G4 and G9 types were continually
detected, with G1 being the most common type in
2001, 2002 and 2004. A G4 epidemic occurred in
2003, while G9 was predominant in 2005. G2 strains
displayed a low prevalence, except in 2003. G3 rota-
viruses accounted for 2.7–17% of the gastroenteritis
episodes in 2002–2005. The P-type of a subset of
166 strains confirmed the circulation of the usual
G=P combinations, but single G1P[6], G9P[9] and
G6P[9] strains were also found.

Group A rotaviruses (HRV) are common agents of
enteritis in infants and young children worldwide
[16]. Classification of HRV strains is based on the
antigenic differences of the two outer capsid pro-
teins VP4 and VP7, both of which induce neutraliz-
ing antibodies, and are encoded by the genomic
segments 4 and 9, respectively [12, 16]. The seg-
mented nature of the rotavirus genome enables the
outer capsid genes to segregate independently. Thus
far, at least 15 G (VP7-specific) and 26 P (VP4-
specific) rotavirus types have been recognised, of
which 11 and 13, respectively, have been found in
various combinations in humans [12, 17, 19, 20, 22].
HRV strains with G1P[8] specificity are universally
acknowledged as the most prevalent and ubiquitous.
Strains with G2P[4], G3P[8] and G4P[8] specificity
are widely dispersed but their incidence varies re-
gionally and temporally [12]. Since 1996, HRV
strains of the G9P[6] or G9P[8] type have been
identified as the fifth most common strain globally,
while other G types and G=P combinations seem to
be sporadic or only of regional relevance [11].
Surveillance of the HRV types involved in gas-
troenteritis episodes throughout the world has been
used to define the appropriate vaccine formulations
to prevent HRV infections in paediatric populations.
Taking into account the antigenic heterogeneity of
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rotaviruses, vaccines matching the most common
rotavirus antigenic profiles have been developed,
and recently, two of these (RotaTeq and Rotarix)
have been also licensed [24, 27].
In Italy, limited data are available on the patterns
of distribution of HRV G and P types. However, in
Palermo, Sicily, epidemiological surveillance for
HRV enteritis in children has been carried out un-
interruptedly since 1985 [1–3, 8]. Over a 20-year
period, the rate of HRV infections has been con-
stantly high in Sicily, with HRV being responsible
for approximately 25–50% of paediatric hospital-
izations due to enteritis. Strains with G1–G4 spec-
ificities accounted for more than 90% of HRV
infections until 1999, when HRVs of the G9P[8]
type emerged and became the third most frequent
HRV G type [3].
Here, we report the data on the surveillance ac-
tivity carried out in Palermo in the years 2001–
2005. A total of 1030 stool samples were obtained
from patients, aged less than five years, admitted
with acute gastroenteritis at the ‘‘G. Di Cristina’’
Children’s Hospital of Palermo in the years 2001–
2005. HRV-positive specimens, detected by enzyme
immunoassay (IDEIA Rotavirus; DakoCytomation
Ltd, Ely, UK), were characterized for VP7 specifi-
city by serotyping; G1–G4 monoclonal antibodies
(RV4:2, RV5:3, RV3:1 and ST3-3:1) were used as
described previously [9]. Subsets of G-serotyped
HRVs and all of the G-unserotypeable strains were
submitted to genotyping with type-specific prim-
ers by a semi-nested PCR strategy. In the first-
round PCR, the full-length VP7 gene was amplified
using conserved oligonucleotide primer pair Beg9=
End9, and the G types were subsequently predicted
in a second-round PCR using a pool of internal
primers specific for the G1–G4 and G9 genotypes
in combination with the reverse consensus primer
[14, 15, 19].
Characterization of the VP4 specificity was car-
ried out similarly using the generic primers Con3
and Con2 and the internal primers specific for the
P[4], P[6], P[8], P[9] and P[11] genotypes [13, 15].
HRV infection was detected in 411 (39.9%) out
of 1030 children examined. The yearly prevalence
ranged from 24.7% in 2003 to 53.4% in 2005.
Most of the infections (73%) occurred between
November and April. The distribution of the vari-
ous G types is described in Table 1. G1 was the
most common serotype detected throughout the
study. G1 HRVs were predominant in 2001 (66.0%),
in 2002 (88.0%) and in 2004 (78.0%). G2 preva-
lence was low (0–4.9%), except in 2003, when
it was the second most common G type (22.6%).
Strains of the G3 type were not detected in 2001,
while they accounted for 2.7, 17.0, 7.3 and 16.9%
of the infections in 2002, 2003, 2004 and 2005, re-
spectively. Similar to G1 strains, G4 and G9 strains
were detected over the entire study period. G4 rep-
resented the most common G type (41.5%) in 2003,
while G9 was the most common G type in 2005
(60.8%). Mixed G types were rarely detected (1.7%).
Six HRV strains were untypeable by both serotyp-
ing and genotyping.
VP4 characterization was performed on a subset
of 166 HRV strains. As expected, almost all of the
G1, G3, G4 and G9 strains tested exhibited the P[8]-
type and all the G2 strains were P[4]-type. Two un-
usual G=P combination (G1P[6] and G9P[9]) were
found. A strain exhibiting the P[9]-type could be
Table 1. Distribution of group A rotavirus G types circulating in infants and young children (<5 years) with acute
gastroenteritis in Palermo, Italy, during a 5-years follow-up (2001–2005)




G1 (%) G2 (%) G3 (%) G4 (%) G9 (%) Non
typeable (%)
2001 159 53 (33.3) 35 (66) 0 0 9 (17) 7 (13.2) 2 (3.8)
2002 181 75 (41.4) 66 (88) 1 (1.3) 2 (2.7) 2 (2.7) 3 (4) 1 (1.3)
2003 214 53 (24.7) 7 (13.2) 12 (22.6) 9 (17) 22 (41.5) 2 (3.8) 1 (1.9)
2004 199 82 (41.2) 64 (78) 4 (4.9) 6 (7.3) 5 (6.1) 3 (3.7) 0
2005 277 148 (53.4) 24 (16.2) 1 (0.7) 25 (16.9) 6 (4) 90 (60.8) 2 (1.3)
Total 1030 411 (39.9) 196 (47.7) 18 (4.4) 42 (10.2) 44 (10.7) 105 (25.5) 6 (1.5)
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defined as G6 only after sequence analysis of the
first-step VP7 amplicon (data not shown).
This study confirms the important role of HRVs
as agents of enteritis in the Italian paediatric popu-
lation and highlights the high prevalence of strains
of the G1–G4 and G9 types. These findings mirror
the epidemiological data described in the European
countries, in North America, in Australia and in
New Zealand and differ from those observed in
developing countries [10, 15, 25]. In the years
2001–2005, G1 and G9 types represented the most
diffuse HRV strains in the paediatric population of
Palermo. G1 strains were predominant in 2001
(66%), 2002 (88%) and 2004 (78%), and their pre-
valence decreased in 2003 when a G4 epidemic
occurred. Since 1985, a similar trend had been ob-
served in Italy in 1991, 1993 and 1999 [4, 5, 16].
G9 HRV strains were detected for the first time
in Italy in 1999 [3]. In 2005, G9 represented the
most common isolates in Sicily, accounting for
60.8% of HRV infections. Likewise, high rates of
detection of G9 strains were reported in Bari, Italy,
in 2001–2002 [18], in Hungary in 2002–2003 [7],
and in Belgium in 2000–2001 and 2002–2003 [21].
G9 HRVs were also found to be predominant (up to
89.2%) in Salvador, Brazil, in 1999, 2000, and again
in 2002, thus demonstrating that they can maintain
predominance during multiple consecutive rota-
virus seasons [26]. Accordingly, the pattern of fluc-
tuation of G9 HRVs appears to be similar to the
patterns exhibited by G1 and G4 HRV strains rather
than to that of G2 strains. Indeed, since their emer-
gence, G9 HRV strains have been detected every
year in Italian children, while G2 strains have com-
pletely disappeared in some years, as observed in
1987, 1990–1991, 1994, 2000 and 2001 [1–3, 5].
G2 was the most common type only in 1996, while
in 2003 it was the second most diffuse type (22.6%).
Likewise, low circulation rates have been reported
for the G2 serotype HRVs in Europe [10].
Sequence analysis of the VP7 and VP4 genes of
the HRV strains detected in Sicily over 20 years has
revealed different evolutionary patterns for rotavirus
G1, G2 and G4 strains. Intra-serotypic variation ap-
pears to be much higher within G1 than G2 and G4.
The continuous predominance of G1 strains over
consecutive years was apparently related to alternate
circulation of an heterogeneous population of lin-
eages and sub-lineages, with repeated introductions
of novel G1 strains [6]. Conversely, homogeneous
populations of G4 and of G2 strains have been cir-
culating for one or more consecutive years, and
peaks of prevalence by G4P[8] and G2P[4] HRVs
were due to the introduction in the Sicilian infantile
population of new rotavirus strains rather than to the
re-emergence of old epidemic strains [4, 5].
In the past, in Italy, G3 HRVs have been detected
sporadically or at very low prevalence [1–3, 8]. How-
ever, in the years 2003 and 2005 they accounted for
17% of gastroenteritis episodes, thus acquiring an
important epidemiological role. Increased prevalence
of infections by G3 HRVs in children has been also
described in recent years in Ireland and Japan [23, 28].
In summary, the findings of this study extend the
data on rotavirus diversity in Italy. Based on these
results, polyvalent vaccine formulations including
the G1–G4 types would be appropriate, but future
vaccine candidates may also need to include a G9
component, as G9 HRVs are continuously circulat-
ing in Italy. There is concern that the introduction
of human rotavirus vaccines could alter the forces
and balances that drive rotavirus evolution. Contin-
uous epidemiological surveillance is paramount for
understanding the short- and long-term effects of
the vaccines on rotavirus ecology and implement-
ing future vaccine strategies.
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